Xspray
XSPRAY.STXspray Pharma AB (publ) Price (XSPRAY.ST)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
26,593,910
(25.0734)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Xspray Pharma AB (publ)Currency: SEK
| YEAR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
3.64M
+0% |
792.00k
-78% |
331.55k
-58% |
277.00k
-16% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
0.00
+0% |
||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 5.29M | -6,193,000.00 | -4,134,704.00 | 0.00 | 4.80M | 1.41M | 8.87M | 9.53M | 9.19M | ||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
-1,654,000.00
+0% |
6.99M
-522% |
4.47M
-36% |
277.00k
-94% |
-4,803,000.00
-1,834% |
-1,411,000.00
-71% |
-8,870,000.00
+529% |
-9,532,000.00
+7% |
-9,194,000.00
-4% |
||||||||||
| Gross Profit Ratio | (-0.45%) | (8.82%) | (13.47%) | (1.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | ||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 3.35M | 5.54M | 3.43M | 6.55M | 38.57M | 22.22M | 33.59M | ||||||||||
| General and Administrative | 4.27M | 3.77M | 8.62M | 0.00 | 42.33M | 47.10M | 58.38M | 109.60M | 0.00 | ||||||||||
| Selling, General & Admin... | 4.27M | 3.77M | 8.62M | 16.97M | 42.33M | 47.10M | 58.38M | 109.60M | 169.57M | ||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 16.97M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Depreciation and Amortiz... | 608.00k | 665.00k | 1.17M | 4.03M | 4.80M | 1.41M | 8.87M | 9.53M | 9.19M | ||||||||||
| Other Expenses | 6.16M | 7.27M | 9.14M | 414.00k | 0.00 | -5,000.00 | 0.00 | -438,000.00 | 0.00 | ||||||||||
| Total Operating Expenses | 10.44M | 11.05M | 17.76M | 22.92M | 45.76M | 53.65M | 96.95M | 131.38M | 181.73M | ||||||||||
| Cost and Exponses | 15.73M | 4.85M | 13.63M | 22.92M | 45.76M | 53.65M | 96.95M | 131.38M | 181.73M | ||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-12,088,000.00
+0% |
-4,059,000.00
-66% |
-13,277,770.00
+227% |
-23,217,000.00
+75% |
-45,705,000.00
+97% |
-53,457,000.00
+17% |
-97,953,000.00
+83% |
-133,073,000.00
+36% |
-180,765,000.00
+36% |
||||||||||
| Operating Income Ratio | (-3.32%) | (-5.13%) | (-40.05%) | (-83.82%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | ||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 21.00k | 80.26k | 150.00k | 862.00k | 1.05M | 1.26M | 1.42M | 2.73M | ||||||||||
| Interest Expenses | 3.00k | 59.00k | 881.00 | 31.00k | 69.00k | 6.00k | 4.00k | 12.00k | 675.00k | ||||||||||
| Total Other Income/Exp... | -3,000.00 | -37,562.00 | -44,000.00 | -458,000.00 | -15,000.00 | 1.05M | 1.26M | 1.40M | 1.08M | ||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -11,480,000.00 | -3,395,386.00 | -12,651,000.00 | -19,071,000.00 | -40,902,000.00 | -50,993,000.00 | -87,824,000.00 | -122,126,000.00 | -169,815,000.00 | ||||||||||
| EBITDA ratio | (-3.15%) | (-4.26%) | (-36.29%) | (-68.20%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | ||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -12,091,000.00 | -4,097,000.00 | -13,198,387.00 | -23,098,000.00 | -45,771,000.00 | -52,410,000.00 | -96,698,000.00 | -131,670,000.00 | -179,684,000.00 | ||||||||||
| Income Before Tax Ratio | (-3.32%) | (-5.17%) | (-39.81%) | (-83.39%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | ||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 2.00k | 22.00k | 98.47k | -427,000.00 | 66.00k | -107,000.00 | 4.00k | -1,403,000.00 | -17,000.00 | ||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -12,091,000.00
+0% |
-4,097,000.00
-66% |
-13,198,387.00
+222% |
-23,098,000.00
+75% |
-45,837,000.00
+98% |
-52,303,000.00
+14% |
-96,702,000.00
+85% |
-130,267,000.00
+35% |
-179,667,000.00
+38% |
||||||||||
| Net Income Ratio | (-3.32%) | (-5.17%) | (-39.81%) | (-83.39%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | (0.00%) | ||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.97 | -0.64 | -1.65 | -1.68 | -2.99 | -3.01 | -4.98 | -6.13 | -6.76 | ||||||||||
| Diluted EPS | -0.97 | -0.33 | -1.56 | -1.63 | -2.99 | -3.01 | -4.98 | -6.13 | -6.76 | ||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 12.47M | 6.41M | 8.02M | 13.72M | 15.35M | 17.37M | 19.41M | 21.26M | 26.58M | ||||||||||
| Diluted Share Outstanding | 12.47M | 12.47M | 8.48M | 14.18M | 15.35M | 17.37M | 19.41M | 21.26M | 26.59M | ||||||||||